Expression of equilibrative nucleoside transporter type 1 protein in elderly patients with schizophrenia

Dan Shan, Vahram Haroutunian, James H. Meador-Woodruff, Robert E. McCullumsmith

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

Alterations in glutamatergic neurotransmission are thought to be involved in several psychiatric disorders, including schizophrenia. Equilibrative nucleoside transporter type 1 (ENT1) regulates glutamate levels by regulating excitatory amino acid transporter expression and activity in the brain. In this study, we investigated whether ENT1 is abnormally expressed in the brain of elderly patients with schizophrenia. We measured protein expression of ENT1 in the superior temporal gyrus (STG) and anterior cingulate cortex (ACC) in patients with schizophrenia (STG, n=22; ACC, n=34) and a comparison group (STG, n=24; ACC, n=29). We found decreased ENT1 expression in the STG in patients with schizophrenia, supporting the hypothesis of altered glutamate transport in this illness.

Original languageEnglish
Pages (from-to)224-227
Number of pages4
JournalNeuroReport
Volume23
Issue number4
DOIs
StatePublished - 7 Mar 2012

Keywords

  • adenosine
  • equilibrative nucleoside transporter 1
  • excitatory amino acid transporter
  • glutamate
  • schizophrenia

Fingerprint

Dive into the research topics of 'Expression of equilibrative nucleoside transporter type 1 protein in elderly patients with schizophrenia'. Together they form a unique fingerprint.

Cite this